173 related articles for article (PubMed ID: 18774496)
21. CD24 expression has a prognostic impact in breast carcinoma.
Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
[TBL] [Abstract][Full Text] [Related]
22. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
23. COX-2 expression does not correlate with microvessel density in breast cancer.
Thorat MA; Mehrotra S; Morimiya A; Badve S
Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
[TBL] [Abstract][Full Text] [Related]
24. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
Goldstein NS
Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
[TBL] [Abstract][Full Text] [Related]
25. [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance].
Wang Y; Zhou ZG; Xia QJ; Zhang WY; Li HG; Wang R
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):465-8. PubMed ID: 18803052
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
27. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.
Sitterding SM; Wiseman WR; Schiller CL; Luan C; Chen F; Moyano JV; Watkin WG; Wiley EL; Cryns VL; Diaz LK
Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of cyclin E in low-risk node negative breast cancer.
Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
[TBL] [Abstract][Full Text] [Related]
29. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
Qureshi HS; Linden MD; Divine G; Raju UB
Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
[TBL] [Abstract][Full Text] [Related]
31. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
Erkus M; Meteoglu I; Culhaci N; Meydan N; Erdogdu I
Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
[TBL] [Abstract][Full Text] [Related]
32. Potential role of minichromosome maintenance protein 2 as a screening biomarker in esophageal cancer high-risk population in China.
Huang B; Hu B; Su M; Tian D; Guo Y; Lian S; Liu Z; Wu X; Li Q; Zheng R; Gao Y
Hum Pathol; 2011 Jun; 42(6):808-16. PubMed ID: 21237484
[TBL] [Abstract][Full Text] [Related]
33. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy.
Freeman A; Morris LS; Mills AD; Stoeber K; Laskey RA; Williams GH; Coleman N
Clin Cancer Res; 1999 Aug; 5(8):2121-32. PubMed ID: 10473096
[TBL] [Abstract][Full Text] [Related]
34. Sarcomatoid breast tumors have sarcomatoid behavior.
Gilcrease MZ
Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
[No Abstract] [Full Text] [Related]
35. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions.
Kunju LP; Ding Y; Kleer CG
Pathol Int; 2008 Oct; 58(10):620-5. PubMed ID: 18801081
[TBL] [Abstract][Full Text] [Related]
36. Surfactant protein A expression in human normal and neoplastic breast epithelium.
Braidotti P; Cigala C; Graziani D; Del Curto B; Dessy E; Coggi G; Bosari S; Pietra GG
Am J Clin Pathol; 2001 Nov; 116(5):721-8. PubMed ID: 11710690
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
38. [Robo1 expression in breast cancer and its relationship to brain metastasis].
Wang J; Wang L; Liu FF; Ma YJ; Fu L; Li WL; Gu F
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):447-51. PubMed ID: 21875486
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
40. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]